High resolution magic angle spinning NMR spectroscopy used to investigate the ability of drugs to bind to synthetic melanin

• Published in: Pigment cell research 2005-02, Vol.18 (1), p.49-54
• Main Authors: Borel, Michèle, Lafarge, David, Moreau, Marie France, Bayle, Martine, Audin, Laurent, Moins, Nicole, Madelmont, Jean-Claude
• Format: Article
• Language: English
• Subjects: drug-melanin interactions; Electron Spin Resonance Spectroscopy; high-resolution magic angle NMR spectroscopy; insoluble melanin; Iodobenzenes - chemistry; line-broadening; Melanins - chemical synthesis; Melanins - chemistry
• ISSN: 0893-5785; 1600-0749
• DOI: 10.1111/j.1600-0749.2004.00210.x

Summary Iodobenzamides are known to possess an affinity for melanoma tissue dependent on tumor pigmentation. In order to investigate the molecular interactions of drugs with melanin in vitro, a synthetic pigment swelled in deuterium buffer at physiological pH was used. The spectra of various mixtures of each Iodobenzamide (BZ) with melanin were studied at 25°C by NMR under MAS conditions. The drug which interacts with the pigment exhibits linewidths greater than those observed for the free drug in solution. Line‐broadening of the resonance occurred for the N‐methyl group of acetylcholine or N‐ethyl and aromatic groups of BZ. However, linewidths associated with methanol or hippuric acid were less altered by the presence of melanin. These observations indicate the specificity of the interaction between some drug moieties and the sites of melanin. From the concentration dependence of line‐broadening, the apparent equilibrium dissociation constant (Kd) of drug interaction with melanin was approached. It seems that the residual concentration‐dependent line‐broadening is caused by perturbations of ligand exchange between free and bound states and by differences in magnetic susceptibility present in the sample at the pigment‐interacting drug moiety interface. Taken together, these results demonstrate the utility of this technique for investigating binding drugs.